SIMILAR PATTERNS OF AMINO ACIDS FOR 4DAJ_D_0HKD2000_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3uon | HUMAN M2 MUSCARINICACETYLCHOLINE,RECEPTOR T4 LYSOZYMEFUSION PROTEIN (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 11 | ASP A 103TYR A 104SER A 107ASN A 108TRP A 155THR A 187THR A 190TRP A 400TYR A 403ASN A 404CYH A 429 | QNB A1162 (-3.1A)QNB A1162 (-4.0A)QNB A1162 (-3.4A)QNB A1162 (-4.9A)QNB A1162 (-4.2A)QNB A1162 (-4.8A)QNB A1162 (-4.3A)QNB A1162 (-4.7A)QNB A1162 (-3.9A)QNB A1162 (-2.9A)QNB A1162 ( 4.0A) | 0.62A | 4dajD-3uonA:39.6 | 4dajD-3uonA:73.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3uon | HUMAN M2 MUSCARINICACETYLCHOLINE,RECEPTOR T4 LYSOZYMEFUSION PROTEIN (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 11 | ASP A 103TYR A 104SER A 107TRP A 155THR A 187THR A 190TRP A 400TYR A 403ASN A 404TYR A 426CYH A 429 | QNB A1162 (-3.1A)QNB A1162 (-4.0A)QNB A1162 (-3.4A)QNB A1162 (-4.2A)QNB A1162 (-4.8A)QNB A1162 (-4.3A)QNB A1162 (-4.7A)QNB A1162 (-3.9A)QNB A1162 (-2.9A)QNB A1162 ( 4.2A)QNB A1162 ( 4.0A) | 0.76A | 4dajD-3uonA:39.6 | 4dajD-3uonA:73.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3uon | HUMAN M2 MUSCARINICACETYLCHOLINE,RECEPTOR T4 LYSOZYMEFUSION PROTEIN (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 6 | ASP A 103TYR A 104THR A 190TRP A 400ASN A 404CYH A 429 | QNB A1162 (-3.1A)QNB A1162 (-4.0A)QNB A1162 (-4.3A)QNB A1162 (-4.7A)QNB A1162 (-2.9A)QNB A1162 ( 4.0A) | 1.48A | 4dajD-3uonA:39.6 | 4dajD-3uonA:73.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 5 | ASP A 103SER A 107TRP A 400TYR A 403ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.4A)IXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A) | 1.29A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 6 | ASP A 103SER A 107TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.4A)IXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.08A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 6 | ASP A 103THR A 187THR A 190TRP A 400TYR A 403ASN A 404 | IXO A 501 (-3.4A)NoneNoneIXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A) | 1.23A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 7 | ASP A 103THR A 187THR A 190TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)NoneNoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.03A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 5 | ASP A 103THR A 190TYR A 403ASN A 404CYH A 429 | IXO A 501 (-3.4A)NoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)IXO A 501 (-3.5A) | 1.29A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 8 | ASP A 103TYR A 104ASN A 108THR A 187THR A 190ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)NoneNoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.95A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 7 | ASP A 103TYR A 104ASN A 108THR A 187THR A 190TRP A 400ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)NoneNoneIXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.15A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 6 | ASP A 103TYR A 104ASN A 108TRP A 155THR A 187TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)NoneIXO A 501 (-4.6A) | 1.23A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 7 | ASP A 103TYR A 104ASN A 108TRP A 155THR A 187TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.98A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 7 | ASP A 103TYR A 104SER A 107ASN A 108ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.96A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 6 | ASP A 103TYR A 104SER A 107ASN A 108TRP A 155TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)IXO A 501 (-4.6A) | 1.06A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 7 | ASP A 103TYR A 104SER A 107ASN A 108TRP A 155TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.91A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 6 | ASP A 103TYR A 104SER A 107ASN A 108TRP A 400ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.15A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homo sapiens) |
PF00001(7tm_1) | 6 | ASP A 103TYR A 104THR A 187ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.48A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4u14 | MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (Escherichiavirus T4;Rattusnorvegicus) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 12 | ASP A 147TYR A 148SER A 151ASN A 152TRP A 199THR A 231THR A 234TRP A 503TYR A 506ASN A 507TYR A 529CYH A 532 | 0HK A2000 (-3.2A)0HK A2000 (-2.8A)0HK A2000 (-3.3A)0HK A2000 ( 4.7A)0HK A2000 (-4.5A)0HK A2000 (-4.3A)None0HK A2000 (-4.3A)0HK A2000 (-4.1A)0HK A2000 (-2.9A)0HK A2000 (-4.1A)0HK A2000 (-3.9A) | 0.43A | 4dajD-4u14A:48.9 | 4dajD-4u14A:95.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4u14 | MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (Escherichiavirus T4;Rattusnorvegicus) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 7 | ASP A 147TYR A 148THR A 231TRP A 503ASN A 507TYR A 529CYH A 532 | 0HK A2000 (-3.2A)0HK A2000 (-2.8A)0HK A2000 (-4.3A)0HK A2000 (-4.3A)0HK A2000 (-2.9A)0HK A2000 (-4.1A)0HK A2000 (-3.9A) | 1.47A | 4dajD-4u14A:48.9 | 4dajD-4u14A:95.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (Escherichiavirus T4;Rattusnorvegicus) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 12 | ASP A 147TYR A 148SER A 151ASN A 152TRP A 199THR A 231THR A 234TRP A 503TYR A 506ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)None3C0 A1202 (-4.4A)NoneNone3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.46A | 4dajD-4u16A:35.5 | 4dajD-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (Escherichiavirus T4;Rattusnorvegicus) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 8 | ASP A 147TYR A 148SER A 151THR A 231TRP A 503ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)None3C0 A1202 ( 4.0A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.40A | 4dajD-4u16A:35.5 | 4dajD-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (Escherichiavirus T4;Rattusnorvegicus) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 6 | TYR A 148SER A 151ASN A 152TRP A 199TRP A 503TYR A 529 | 3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)None3C0 A1202 (-4.4A)3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A) | 1.48A | 4dajD-4u16A:35.5 | 4dajD-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5cxv | MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1 (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 11 | ASP A 105TYR A 106SER A 109TRP A 157THR A 189THR A 192TRP A 378TYR A 381ASN A 382TYR A 404CYH A 407 | 0HK A 501 (-3.0A)0HK A 501 (-3.4A)0HK A 501 (-3.1A)0HK A 501 (-4.0A)0HK A 501 (-4.4A)0HK A 501 (-4.0A)0HK A 501 (-4.4A)0HK A 501 (-4.1A)0HK A 501 (-2.8A)0HK A 501 (-3.6A)0HK A 501 (-3.7A) | 0.61A | 4dajD-5cxvA:43.0 | 4dajD-5cxvA:74.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5cxv | MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1 (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 7 | ASP A 105TYR A 106THR A 192TRP A 378ASN A 382TYR A 404CYH A 407 | 0HK A 501 (-3.0A)0HK A 501 (-3.4A)0HK A 501 (-4.0A)0HK A 501 (-4.4A)0HK A 501 (-2.8A)0HK A 501 (-3.6A)0HK A 501 (-3.7A) | 1.22A | 4dajD-5cxvA:43.0 | 4dajD-5cxvA:74.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dsg | MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4 (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 12 | ASP A 112TYR A 113SER A 116ASN A 117TRP A 164THR A 196THR A 199TRP A 413TYR A 416ASN A 417TYR A 439CYH A 442 | 0HK A1201 (-4.0A)0HK A1201 ( 3.2A)0HK A1201 (-3.3A)OLC A1208 ( 3.6A)OLC A1208 ( 4.0A)P6G A1205 (-4.6A)OLC A1208 (-4.4A)0HK A1201 (-4.3A)0HK A1201 (-4.2A)0HK A1201 (-2.8A)0HK A1201 (-3.6A)0HK A1201 (-3.6A) | 0.57A | 4dajD-5dsgA:42.1 | 4dajD-5dsgA:66.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dsg | MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4 (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 7 | ASP A 112TYR A 113THR A 196TRP A 413ASN A 417TYR A 439CYH A 442 | 0HK A1201 (-4.0A)0HK A1201 ( 3.2A)P6G A1205 (-4.6A)0HK A1201 (-4.3A)0HK A1201 (-2.8A)0HK A1201 (-3.6A)0HK A1201 (-3.6A) | 1.49A | 4dajD-5dsgA:42.1 | 4dajD-5dsgA:66.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lkd | GLUTATHIONES-TRANSFERASEOMEGA-LIKE 2 (Saccharomycescerevisiae) |
PF13409(GST_N_2)PF13410(GST_C_2) | 5 | ASP A 247ASN A 240THR A 226ASN A 308TYR A 316 | None | 1.41A | 4dajD-5lkdA:0.0 | 4dajD-5lkdA:22.31 |